The Latest Updates on Managing Your Patients With Antimicrobial Resistant Gram-Negative Infections : Episode 2

Impact of 2023 Updated IDSA Guidelines on Antimicrobial Resistant Gram-Negative Infection Treatment

November 1, 2023

Opinion

Video

Dr Christian Sandrock evaluates the impact of 2023 updated IDSA guidelines on treatment decisions for patients with antimicrobial resistant gram-negative infections and for patients with multidrug-resistant pathogens.

EP: 1.2023 Updated IDSA Guidelines For Antimicrobial Resistant Gram-Negative Infections

Now Viewing

EP: 2.Impact of 2023 Updated IDSA Guidelines on Antimicrobial Resistant Gram-Negative Infection Treatment

EP: 3.Treatment Approaches for Polymicrobial Infections

EP: 4.Key Takeaways on Managing Antimicrobial Resistant Gram-Negative Infections

Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.

Subscribe Now!

Impact of 2023 Updated IDSA Guidelines on Antimicrobial Resistant Gram-Negative Infection Treatment

EP: 1.2023 Updated IDSA Guidelines For Antimicrobial Resistant Gram-Negative Infections

EP: 2.Impact of 2023 Updated IDSA Guidelines on Antimicrobial Resistant Gram-Negative Infection Treatment

EP: 3.Treatment Approaches for Polymicrobial Infections

EP: 4.Key Takeaways on Managing Antimicrobial Resistant Gram-Negative Infections

Newsletter